3 results
Approved WMORecruiting
Does single subcutaneous injection with denosumab or placebo (NACL 0.9%) induces a shorter Total contact cast treatment duration and faster bonefracture healing (days) and does it prevent deformation of the foot in patients with Charcot foot
Approved WMORecruiting
To investigate whether 3 monthly Dmab will improve the clinical, radiological and biochemical manifestations of FD bone lesions.
Approved WMORecruiting
The aim of this prospective observational study is to assess the relation between femoral component rotation and patient reported outcomes in a large group of patients, and to define a clear cut-off point for revision for malrotated components.The…